Mutations

Dutch scientists build colon cancer progression model

Scientists from the Hubrecht Institute and the University Medical Center Utrecht (UMC Utrecht) have developed a cell culture model of human colon cancer progression. This model mimics the situation in patients more closely than any other colon cancer model so far. It enables researchers to study processes involved in colon cancer development and find new cancer drugs.

Intestinalorganoids.
Intestinalorganoids.
Source: UMC Utrecht

Colon cancer is one of the most common and deadly forms of cancer. Like all cancers, it arises through an accumulation of DNA changes (mutations) in the cell’s genome (the genetic information in a cell). In contrast to healthy cells, many colon cancer cells have very unstable genomes and generally contain hundreds to thousands of mutations. This makes it difficult to determine which mutations are essential for cancer development and survival. Those mutations could be targeted for therapeutic intervention. However, until now no good human model systems to study such mutations exist.

Organoids

The recent development of the organoid technology by the research group of Hans Clevers allows the culturing of healthy human tissues under laboratory conditions. Organoids functionally recapitulate the organ of origin and are genetically stable. Utilizing this technology, the Clevers lab has now successfully engineered a colon cancer progression model in organoids from human small intestine and colon.

Genome editing

Jarno Drost, researcher in Hans Clevers’ research group, and his colleagues utilized the genome editing system CRISPR/Cas9 to introduce specific mutations in four of the most commonly altered genes in colon cancer (KRAS, APC, TP53 and SMAD4) and performed an in-depth analysis on their contribution to cancer development. Drost and colleagues showed that mutating these four genes is sufficient to convert a healthy intestinal cell into an invasive tumor cell. The model published in Nature can be used to study processes involved in colon cancer development and for cancer drug discovery.

 

Reference
Drost J, Van Jaarsveld RH, Ponsioen B, Zimberlin C, Van Boxtel R, Buijs A, et al. Sequential cancer mutations in cultured human intestinal stem cells.  Nature, 29 April 2015.


Source: UMC Utrecht

04.05.2015

Read all latest stories

Related articles

Photo

Datasets

Benefits from The Cancer Genome Atlas

Last year, scientists at the University of California San Francisco (UCSF) revealed that by measuring the proportion of both immune and cancerous cells in tumours, or ‘tumour purity,’ clinicians…

Photo

Research

New revolutionary culturing technique for liver and pancreas

Researchers at the Hubrecht Institute and the University Medical Center (UMC) Utrecht successfully developed a culturing system for human liver stem cells as well as stem cells from pancreatic…

Photo

Oncology

One cancer – many tumors

In studies on prostate cancer, scientists from the German Cancer Research Center (DKFZ) simultaneously investigated the genetic and epigenetic development of the tumors.

Related products

Orion Diagnostica Oy – Orion GenRead

Amplification

Orion Diagnostica Oy – Orion GenRead

Orion Diagnostics Oy
Sarstedt – Low DNA Binding Micro Tubes

Research Use Only (RUO)

Sarstedt – Low DNA Binding Micro Tubes

SARSTEDT AG & CO. KG
Sarstedt – White Multiply PCR Plates

Amplification

Sarstedt – White Multiply PCR Plates

SARSTEDT AG & CO. KG
i-Solutions Health – LabCentre

LIS, Middleware, POCT

i-Solutions Health – LabCentre

i-SOLUTIONS Health GmbH
Medat – Laboratory Information System

LIS, Middleware, POCT

Medat – Laboratory Information System

Medat Computer-Systeme GmbH